TRxADE HEALTH, Inc. (MEDS) shares are surging more than 81 percent on Monday morning trade, continuing an upsurge. The shares have been gaining momentum since the company announced the approval of its board for 1-for15 reverse stock split on June 21.
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also fell, dropping, 0.19% to 4,340.11.